Literature DB >> 14681220

Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides.

Bing-Hao Luo1, Junichi Takagi, Timothy A Springer.   

Abstract

Although integrin alpha subunit I domains exist in multiple conformations, it is controversial whether integrin beta subunit I-like domains undergo structurally analogous movements of the alpha7-helix that are linked to affinity for ligand. Disulfide bonds were introduced into the beta(3) integrin I-like domain to lock its beta6-alpha7 loop and alpha7-helix in two distinct conformations. Soluble ligand binding, ligand mimetic mAb binding and cell adhesion studies showed that disulfide-bonded receptor alpha(IIb)beta(3)(T329C/A347C) was locked in a low affinity state, and dithiothreitol treatment restored the capability of being activated to high affinity binding; by contrast, disulfide-bonded alpha(IIb)beta(3)(V332C/M335C) was locked in a high affinity state. The results suggest that activation of the beta subunit I-like domain is analogous to that of the alpha subunit I domain, i.e. that axial movement in the C-terminal direction of the alpha7-helix is linked to rearrangement of the I-like domain metal ion-dependent adhesion site into a high affinity conformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14681220     DOI: 10.1074/jbc.M312732200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Identification of integrin beta subunit mutations that alter heterodimer function in situ.

Authors:  Alison L Jannuzi; Thomas A Bunch; Robert F West; Danny L Brower
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

2.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.

Authors:  Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-Huai Wang; Timothy A Springer
Journal:  Nature       Date:  2004-09-19       Impact factor: 49.962

3.  The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7.

Authors:  JianFeng Chen; Junichi Takagi; Can Xie; Tsan Xiao; Bing-Hao Luo; Timothy A Springer
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

4.  Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2.

Authors:  Xing Chen; Can Xie; Noritaka Nishida; Zongli Li; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Modulation of integrin activation by an entropic spring in the {beta}-knee.

Authors:  Benoit J Smagghe; Po-Ssu Huang; Yih-En Andrew Ban; David Baker; Timothy A Springer
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

6.  Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3.

Authors:  Robert Blue; Jihong Li; Jonathan Steinberger; Marta Murcia; Marta Filizola; Barry S Coller
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

7.  Identification of interacting hot spots in the beta3 integrin stalk using comprehensive interface design.

Authors:  Jason E Donald; Hua Zhu; Rustem I Litvinov; William F DeGrado; Joel S Bennett
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

Review 8.  Integrin structures and conformational signaling.

Authors:  Bing-Hao Luo; Timothy A Springer
Journal:  Curr Opin Cell Biol       Date:  2006-08-14       Impact factor: 8.382

9.  Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2.

Authors:  JianFeng Chen; Wei Yang; Minsoo Kim; Christopher V Carman; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

10.  A small molecule agonist of an integrin, alphaLbeta2.

Authors:  Wei Yang; Christopher V Carman; Minsoo Kim; Azucena Salas; Motomu Shimaoka; Timothy A Springer
Journal:  J Biol Chem       Date:  2006-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.